| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/11/2004 | WO2004020081A2 Production of variable concentration fluid mixtures |
| 03/11/2004 | WO2004020067A1 Thermoelectric condenser for vapour exhaled during respiration |
| 03/11/2004 | WO2004020065A2 Microfluidic affinity system using polydimethylsiloxane and a surface modification process |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent |
| 03/11/2004 | WO2004019976A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | WO2004019973A1 Use of protein kinase n beta |
| 03/11/2004 | WO2004019967A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 03/11/2004 | WO2004019886A2 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | WO2004019882A2 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS |
| 03/11/2004 | WO2004019875A2 Non-invasive methods to identify agents for treating pain |
| 03/11/2004 | WO2004019676A2 Animal model for perimenopause and menopause and methods of inducing ovarian failure |
| 03/11/2004 | WO2004007767A3 Serrs reactive particles |
| 03/11/2004 | WO2004007745A3 Method for chemiluminescent detection |
| 03/11/2004 | WO2004007544A3 Components of the presenilin-complex |
| 03/11/2004 | WO2004005922A3 Monitoring of cells |
| 03/11/2004 | WO2004003231A3 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 03/11/2004 | WO2003105675A3 Computerized image capture of structures of interest within a tissue sample |
| 03/11/2004 | WO2003097793A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/11/2004 | WO2003095662A3 Simultaneous detection of two analytes produced by a cell under the influence of a putative agent using a pin coated assay system |
| 03/11/2004 | WO2003095607A3 Role of p62 in aging-related disease |
| 03/11/2004 | WO2003095480A3 Brachyspira hyodysenteriae vaccine |
| 03/11/2004 | WO2003093811A3 Method for characterizing water-in-oil emulsions using electrical wave forms |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003089615A3 Antiviral inhibitions of capsid proteins |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003080097A3 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) |
| 03/11/2004 | WO2003078650A3 Manganese ion regulation of reverse transcriptase activity and methods of modulating same |
| 03/11/2004 | WO2003076941A3 In vitro serological method of diagnosing infective endocarditis |
| 03/11/2004 | WO2003072125A8 Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides |
| 03/11/2004 | WO2003071268A3 Method for discovering pharmacologically active substances |
| 03/11/2004 | WO2003069346A3 Diagnostic method for stroke |
| 03/11/2004 | WO2003067241A3 Gas sensor and method for producing the same |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003060524A3 Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry |
| 03/11/2004 | WO2003059943A3 Conformation-specific, protein kinase binding peptides and related methods and products |
| 03/11/2004 | WO2003058244A3 Method for obtaining a calibration system |
| 03/11/2004 | WO2003055908A3 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 03/11/2004 | WO2003054539A3 Tracking early indicia of beauty treatment progress |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003051395A3 Edg-receptor agonist for the treatment of hypertension |
| 03/11/2004 | WO2003048762A3 System and method for health monitoring of aquatic species |
| 03/11/2004 | WO2003046572A3 Biopolymer markers predictive of alzheimers disease |
| 03/11/2004 | WO2003044490A3 Method for identifying substances in a liquid or gaseous sample |
| 03/11/2004 | WO2003044485A3 Proteonomic methods for diagnosis and monitoring of breast cancer |
| 03/11/2004 | WO2003042396A3 Electronic detection of biological molecules using thin layers |
| 03/11/2004 | WO2003040389A3 Method for identifying endogenic and exogenic substances in an organism |
| 03/11/2004 | WO2003038441A3 Screening methods based on cited family proteins |
| 03/11/2004 | WO2003038436A3 Microfluidic ser(r)s detection |
| 03/11/2004 | WO2003034071A3 A method of forming a dynamic combinatorial library using a scaffold |
| 03/11/2004 | WO2003030621A3 Low-cost on-line and in-line spectral sensors based on solid-state source and detector combinations |
| 03/11/2004 | WO2003027671A3 Apoptosis |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003023400A3 Method and apparatus for assay based on light diffraction |
| 03/11/2004 | WO2003023390A3 Device for monitoring coagulation status |
| 03/11/2004 | WO2003020886A3 Methods and devices for detecting cell-cell interactions |
| 03/11/2004 | WO2003019331A3 Method of conducting and documenting analyte screening tests |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003016858A3 Method and apparatus for selective biological material detection |
| 03/11/2004 | WO2003014960A3 Method of identifying a consensus sequence for intracellular antibodies |
| 03/11/2004 | WO2003014742A3 Identification of human auto-antibodies |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003012393A3 Method of detecting protease activity in a cell |
| 03/11/2004 | WO2002101350A3 Cell migration assay |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002094083A3 Facile diagnosis and monitoring of pneumocystis carinii infection |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002075318A3 Neurofibrillary labels |
| 03/11/2004 | WO2002068602A3 Methods for modulating g2a receptor activity |
| 03/11/2004 | WO2002062135A8 Scce modified transgenic mammals and their use as models of human disease |
| 03/11/2004 | US20040049800 Rapid methods for assessing therapeutic activity using animals expressing constitutively active G protein coupled receptors |
| 03/11/2004 | US20040049799 Method for screening agents capable of treating obesity |
| 03/11/2004 | US20040049355 Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
| 03/11/2004 | US20040049353 System and method for monitoring water using bivalve mollusks |
| 03/11/2004 | US20040049351 Immunosorbent assay in microarray format |
| 03/11/2004 | US20040049350 Prediction of unknown biological function of the active site in proteins or/and polynucleotides, and its utilization |
| 03/11/2004 | US20040049220 Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| 03/11/2004 | US20040049219 Methods and apparatus for lancet actuation |
| 03/11/2004 | US20040049113 Apparatus and method for non-invasively measuring cardiac output |
| 03/11/2004 | US20040049107 Novel detector using mass spectroscopy for characterization of biological community |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049011 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/11/2004 | US20040048817 Methods of immunotherapy and diagnosis |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048810 Sterol glucoside toxins |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040048780 Administering an agent which inhibits protein kinase A phosphorylation of a type 2 ryanodine receptor (RyR2); for treating a subject afflicted with exercise-induced or stress-induced cardiac arrhythmia |
| 03/11/2004 | US20040048397 A method for analyzing a particular component contained in whole blood |
| 03/11/2004 | US20040048396 Facilitating an activity determination for gel-based/ chromatographic-based endpoint or dose response analysis |
| 03/11/2004 | US20040048395 Signal enhancement system with multiple labelled-moieties |
| 03/11/2004 | US20040048394 Improved button layout for a testing instrument for handling sensors that are used in analyzing blood glucose or other analytes contained therein |
| 03/11/2004 | US20040048390 Such as Sialyl Lewis X to detect cancer, or glucose in a sample; use in implantable sensor; compounds are anthracene-containing symmetrical diboronic acids |
| 03/11/2004 | US20040048387 A method of assaying a specific glycated protein in serum |
| 03/11/2004 | US20040048386 Emulating with a cyanide-free lyse solution, the measurement of hemoglobin in whole blood using a cyanide- containing lyse solution |
| 03/11/2004 | US20040048384 Method and device for collecting and stabilizing a biological sample |
| 03/11/2004 | US20040048383 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
| 03/11/2004 | US20040048361 Substrate for microarray |
| 03/11/2004 | US20040048360 Microfluidic analytic detection assays, devices, and integrated systems |